Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination

Sidse Ehmsen; Anders Asmussen; Stefan S. Jeppesen; Anna Christine Nilsson; Sabina Østerlev; Amalie Kragh; Henrik Frederiksen; Henrik J. Ditzel

doi:10.1016/j.ccell.2022.02.011

Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination

Sidse Ehmsen, Anders Asmussen, Stefan S. Jeppesen, Anna Christine Nilsson, Sabina Østerlev, Amalie Kragh, Henrik Frederiksen, Henrik J. Ditzel^*

^*Kontaktforfatter

Odense Universitetshospital

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Cancer Cell
Vol/bind	40
Udgave nummer	4
Sider (fra-til)	338-339
ISSN	1535-6108
DOI	https://doi.org/10.1016/j.ccell.2022.02.011
Status	Udgivet - 11. apr. 2022

Bibliografisk note

Funding Information:
The study was supported by a grant from the Odense University Research Council . The funder had no role in study design, patient recruitment, data collection, data analysis, data interpretation, or writing of the report. We want to express our gratitude to the participants of the study; to laboratory technicians at the Odense University Department of Oncology for technical assistance with the blood samples; and to the Clinical Experimental Unit, Department of Oncology, Odense University Hospital for assistance with the recruitment of patients. We thank M.K. Occhipinti for editorial assistance.

Dokumenter og links

10.1016/j.ccell.2022.02.011

Citationsformater

@article{d0192437b29c4783a5d4594ce56bdf9b,

title = "Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination",

keywords = "Antibody Formation, COVID-19 Vaccines, COVID-19/prevention & control, Humans, Neoplasms/genetics, RNA, Messenger, Vaccination",

author = "Sidse Ehmsen and Anders Asmussen and Jeppesen, {Stefan S.} and Nilsson, {Anna Christine} and Sabina {\O}sterlev and Amalie Kragh and Henrik Frederiksen and Ditzel, {Henrik J.}",

note = "Funding Information: The study was supported by a grant from the Odense University Research Council . The funder had no role in study design, patient recruitment, data collection, data analysis, data interpretation, or writing of the report. We want to express our gratitude to the participants of the study; to laboratory technicians at the Odense University Department of Oncology for technical assistance with the blood samples; and to the Clinical Experimental Unit, Department of Oncology, Odense University Hospital for assistance with the recruitment of patients. We thank M.K. Occhipinti for editorial assistance. ",

year = "2022",

month = apr,

day = "11",

doi = "10.1016/j.ccell.2022.02.011",

language = "English",

volume = "40",

pages = "338--339",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination

AU - Ehmsen, Sidse

AU - Asmussen, Anders

AU - Jeppesen, Stefan S.

AU - Nilsson, Anna Christine

AU - Østerlev, Sabina

AU - Kragh, Amalie

AU - Frederiksen, Henrik

AU - Ditzel, Henrik J.

N1 - Funding Information: The study was supported by a grant from the Odense University Research Council . The funder had no role in study design, patient recruitment, data collection, data analysis, data interpretation, or writing of the report. We want to express our gratitude to the participants of the study; to laboratory technicians at the Odense University Department of Oncology for technical assistance with the blood samples; and to the Clinical Experimental Unit, Department of Oncology, Odense University Hospital for assistance with the recruitment of patients. We thank M.K. Occhipinti for editorial assistance.

PY - 2022/4/11

Y1 - 2022/4/11

KW - Antibody Formation

KW - COVID-19 Vaccines

KW - COVID-19/prevention & control

KW - Humans

KW - Neoplasms/genetics

KW - RNA, Messenger

KW - Vaccination

U2 - 10.1016/j.ccell.2022.02.011

DO - 10.1016/j.ccell.2022.02.011

M3 - Comment/debate

C2 - 35216675

AN - SCOPUS:85127543458

SN - 1535-6108

VL - 40

SP - 338

EP - 339

JO - Cancer Cell

JF - Cancer Cell

IS - 4

ER -